MRK vs RUN · P/E 33, rev $65.01B vs P/E 6.0, rev $2.04B
Merck & Company Inc (MRK) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported MRK revenue for 2025-12-31 was $65.01B. Net income was $18.25B. Revenue was up 1.3% from 2024-12-31 to 2025-12-31. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the MRK and RUN stock pages for the full models.
Not investment advice.